The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Genomewide association study of Parkinson's disease clinical biomarkers in 12 longitudinal patients' cohorts
Open accessAbstract
Background: Several reports have identified different patterns of Parkinson's disease progression in individuals carrying missense variants in GBA or LRRK2 genes. The overall contribution of genetic factors to the severity and progression of Parkinson's disease, however, has not been well studied. Objectives: To test the association between genetic variants and the clinical features of Parkinson's disease on a genomewide scale. Methods: We accumulated individual data from 12 longitudinal cohorts in a total of 4093 patients with 22,307 observations for a median of 3.81 years. Genomewide associations were evaluated for 25 cross‐sectional and longitudinal phenotypes. Specific variants of interest, including 90 recently identified disease‐risk variants, were also investigated post hoc for candidate associations with these phenotypes. Results: Two variants were genomewide significant. Rs382940(T>A), within the intron of SLC44A1, was associated with reaching Hoehn and Yahr stage 3 or higher faster (hazard ratio 2.04 [1.58–2.62]; P value = 3.46E‐8). Rs61863020(G>A), an intergenic variant and expression quantitative trait loci for α‐2A adrenergic receptor, was associated with a lower prevalence of insomnia at baseline (odds ratio 0.63 [0.52–0.75]; P value = 4.74E‐8). In the targeted analysis, we found 9 associations between known Parkinson's risk variants and more severe motor/cognitive symptoms. Also, we replicated previous reports of GBA coding variants (rs2230288: p.E365K; rs75548401: p.T408M) being associated with greater motor and cognitive decline over time, and an APOE E4 tagging variant (rs429358) being associated with greater cognitive deficits in patients. Conclusions: We identified novel genetic factors associated with heterogeneity of Parkinson's disease. The results can be used for validation or hypothesis tests regarding Parkinson's disease. © 2019 International Parkinson and Movement Disorder Society
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment
Nasreddine, Z. S., Phillips, N. A., Bédirian, V., Charbonneau, S., Whitehead, V., Collin, I., Cummings, J. L., & Chertkow, H. (2005) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.53221.x · Cited by 25,553
MDS clinical diagnostic criteria for Parkinson’s disease
Postuma, R. B., Berg, D., Stern, M., Poewe, W., Olanow, C. W., Oertel, W., Obeso, J., Marek, K., Litvan, I., Lang, A. E., et al. (2015) · Movement Disorders · doi:10.1002/mds.26424 · Cited by 7,653
Self-citationMETAL: fast and efficient meta-analysis of genomewide association scans
Willer, C. J., Li, Y., & Abecasis, G. R. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq340 · Cited by 5,205
Functional mapping and annotation of genetic associations with FUMA
Watanabe, K., Taskesen, E., van Bochoven, A., & Posthuma, D. (2017) · Nature Communications · doi:10.1038/s41467-017-01261-5 · Cited by 4,083
Next-generation genotype imputation service and methods
Das, S., Forer, L., Schönherr, S., Sidore, C., Locke, A. E., Kwong, A., Vrieze, S. I., Chew, E. Y., Levy, S., McGue, M., et al. (2016) · Nature Genetics · doi:10.1038/ng.3656 · Cited by 3,808
Integrating common and rare genetic variation in diverse human populations
The International HapMap 3 Consortium (2010) · Nature · doi:10.1038/nature09298 · Cited by 3,026
LocusZoom: regional visualization of genome-wide association scan results
Pruim, R. J., Welch, R. P., Sanna, S., Teslovich, T. M., Chines, P. S., Gliedt, T. P., Boehnke, M., Abecasis, G. R., & Willer, C. J. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq419 · Cited by 2,707
Võsa, U., Claringbould, A., Westra, H.-J., Bonder, M. J., Deelen, P., Zeng, B., Kirsten, H., Saha, A., Kreuzhuber, R., Yazar, S., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00913-z · Cited by 2,607
Using genome-wide complex trait analysis to quantify ‘missing heritability’ in Parkinson’s disease
Keller, M. F., Saad, M., Bras, J., Bettella, F., Nicolaou, N., Simon-Sanchez, J., Mittag, F., Buchel, F., Sharma, M., Gibbs, J. R., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds335 · Cited by 190 · cited 1×
“Recent genomewide studies have identified 90 common variants associated with the risk of PD, with an overall heritability estimated to be between 22% to 27%.(2,3) Although previous studies have indicated the importance of genetic contributions to disease risk, the contribution of genetic factors to PD progression and…”
BackgroundSelf-citation
Research works printed but not linked: 32
- Nalls MA, Expanding Parkinson's disease genetics: novel risk loci, genomic context, causal insights and heritable risk [published online ahead of print 2019], bioRxiv
- Leonard H, Genetic variability and potential effects on clinical trial outcomes: perspectives in Parkinson's disease [published online ahead of print 2018], bioRxiv
- 10.1002/mds.20213 · DOI · Paper page
- 10.1002/mds.21198 · DOI · Paper page
- 10.1016/j.neurobiolaging.2014.07.028 · DOI
- 10.1086/519795 · DOI · Paper page
- 10.1093/bioinformatics/btw079 · DOI · Paper page
- SäfkenB RügamerD KneibT GrevenS. Conditional model selection in mixed‐effects models with cAIC4 [published online ahead of print March 15 2018]. arXiv:1803.05664. · arXiv
- Võsa U, Unraveling the polygenic architecture of complex traits using blood eQTL meta‐analysis [published online ahead of print October 19, 2018], bioRxiv
- 10.1038/s41467-018-04558-1 · DOI · Paper page
- 10.1016/j.neulet.2017.08.040 · DOI
- 10.1002/mds.103 · DOI
- 10.1212/NXG.0000000000000348 · DOI
- 10.1111/j.1471-4159.2009.06218.x · doi:10.1111/j.1471-4159.2009.06218.x
- 10.1096/fj.14-258566 · DOI
- 10.1074/jbc.M116.747816 · DOI
- 10.1016/j.gene.2018.02.007 · doi:10.1016/j.gene.2018.02.007
- 10.1111/ejn.12570 · DOI
- 10.1038/s41593-018-0223-0 · DOI
- 10.1001/archneur.63.12.1724 · DOI
- 10.1016/j.bbr.2004.03.002 · DOI
- 10.1126/science.aaf3934 · DOI · Paper page
- 10.1093/brain/aws318 · DOI · Paper page
- 10.1002/mds.26071 · DOI · Paper page
- 10.1016/j.neurobiolaging.2015.09.014 · DOI
- 10.1001/jamaneurol.2016.2245 · DOI · Paper page
- 10.1002/ana.24781 · DOI · Paper page
- 10.1001/archneur.63.2.189 · DOI · Paper page
- 10.1177/0891988709332945 · DOI
- 10.1016/j.nbd.2012.02.002 · DOI
- 10.1001/jamaneurol.2014.1455 · DOI · Paper page
- 10.3233/JPD-150762 · DOI
Cited by
Parkinson disease-associated cognitive impairment
Aarsland, D., Batzu, L., Halliday, G. M., Geurtsen, G. J., Ballard, C., Ray Chaudhuri, K., & Weintraub, D. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00280-3 · Cited by 1,371
Self-citationThe genetic architecture of Parkinson's disease
Blauwendraat, C., Nalls, M. A., & Singleton, A. B. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30287-x · Cited by 1,114
Self-citationGenetics of Parkinson's disease: An introspection of its journey towards precision medicine
Bandres-Ciga, S., Diez-Fairen, M., Kim, J. J., & Singleton, A. B. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104782 · Cited by 370
Self-citationType 2 Diabetes as a Determinant of Parkinson's Disease Risk and Progression
Chohan, H., Senkevich, K., Patel, R. K., Bestwick, J. P., Jacobs, B. M., Bandres Ciga, S., Gan‐Or, Z., & Noyce, A. J. (2021) · Movement Disorders · doi:10.1002/mds.28551 · Cited by 228
Self-citationAllele-specific open chromatin in human iPSC neurons elucidates functional disease variants
Zhang, S., Zhang, H., Zhou, Y., Qiao, M., Zhao, S., Kozlova, A., Shi, J., Sanders, A. R., Wang, G., Luo, K., et al. (2020) · Science · doi:10.1126/science.aay3983 · Cited by 127
Metadata
- Authors
- Iwaki, H., Blauwendraat, C., Leonard, H. L., Kim, J. J., Liu, G., Maple‐Grødem, J., Corvol, J., Pihlstrøm, L., van Nimwegen, M., Hutten, S. J., Nguyen, K. H., Rick, J., Eberly, S., Faghri, F., Auinger, P., Scott, K. M., Wijeyekoon, R., Van Deerlin, V. M., Hernandez, D. G., Gibbs, J. R., International Parkinson's Disease Genomics Consortium, Chitrala, K. N., Day‐Williams, A. G., Brice, A., Alves, G., Noyce, A. J., Tysnes, O., Evans, J. R., Breen, D. P., Estrada, K., Wegel, C. E., Danjou, F., Simon, D. K., Andreassen, O., Ravina, B., Toft, M., Heutink, P., Bloem, B. R., Weintraub, D., Barker, R. A., Williams‐Gray, C. H., van de Warrenburg, B. P., Van Hilten, J. J., Scherzer, C. R., Singleton, A. B., & Nalls, M. A.
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2019-09-10
- Volume
- 34
- Issue
- 12
- Pages
- 1839-1850
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W2972719726
- Cited by
- 170
- References
- 9
- FWCI
- 13.14
- Type
- journal article
- Language
- en
- Open access
- green
- Funders
- Biogen Idec
- Michael J. Fox Foundation for Parkinson's Research
- National Institute on Aging (Z01‐AG000949‐02)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Genomewide association study of Parkinson's disease clinical biomarkers in 12 longitudinal patients' cohorts. https://app.cochat.ai/papers/10.1002/mds.27845
- The paper
- Iwaki, H., Blauwendraat, C., Leonard, H. L., Kim, J. J., Liu, G., Maple‐Grødem, J., Corvol, J., Pihlstrøm, L., van Nimwegen, M., Hutten, S. J., Nguyen, K. H., Rick, J., Eberly, S., Faghri, F., Auinger, P., Scott, K. M., Wijeyekoon, R., Van Deerlin, V. M., Hernandez, D. G., . . . Nalls, M. A. (2019). Genomewide association study of Parkinson's disease clinical biomarkers in 12 longitudinal patients' cohorts. Movement Disorders. https://doi.org/10.1002/mds.27845
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.